Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-11-6
pubmed:abstractText
Granulomatous inflammation in schistosomiasis is a delayed-type hypersensitivity reaction mediated by CD4+ T cells specific for parasite egg antigens (Ags). In an attempt to control T-cell responses leading to excessive harmful inflammation and granuloma formation, especially in the liver, BALB/c mice were intranasally (i.n.) treated with soluble Schistosoma mansoni egg Ags (SEA) conjugated to cholera toxin B subunit (CTB), a mucosa-binding protein with demonstrated capacity to suppress inflammatory T-cell functions after mucosal administration. Treatment with CTB-SEA significantly conjugate a reduced liver granuloma formation in infected mice associated with decreased SEA specific Th1- and Th2-type immune responses by liver leukocytes. Importantly, treatment with CTB-SEA conjugate also significantly reduced the mortality in chronically infected mice. In S. mansoni-infected large-granuloma forming CBA mice, i.n. treatment with purified Sm-p40, the major egg antigen, conjugated to CTB likewise significantly inhibited hepatic egg granuloma formation. A reduction of SEA-driven lymphoproliferation and of interferon (IFN)-gamma, interleukin (IL)-4 and IL-5 production, together with an increase in transforming growth factor (TGF)-beta1 production, were observed in splenic cells from CTB-Sm-p40-treated SEA-sensitized mice, as well as in liver leukocytes from CTB-Sm-p40-treated schistosome-infected mice. These results indicate that mucosal administration of SEA or purified Sm-p40 antigen in conjunction with CTB is highly effective in curtailing immunopathologic manifestations of schistosomiasis in vivo in infected hosts.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0300-9475
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
440-7
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11696194-Administration, Intranasal, pubmed-meshheading:11696194-Animals, pubmed-meshheading:11696194-Antigens, Helminth, pubmed-meshheading:11696194-Cholera Toxin, pubmed-meshheading:11696194-Female, pubmed-meshheading:11696194-Granuloma, pubmed-meshheading:11696194-Helminth Proteins, pubmed-meshheading:11696194-Immunity, Mucosal, pubmed-meshheading:11696194-Liver, pubmed-meshheading:11696194-Liver Diseases, pubmed-meshheading:11696194-Mice, pubmed-meshheading:11696194-Mice, Inbred BALB C, pubmed-meshheading:11696194-Mice, Inbred CBA, pubmed-meshheading:11696194-Ovum, pubmed-meshheading:11696194-Schistosoma mansoni, pubmed-meshheading:11696194-Schistosomiasis mansoni, pubmed-meshheading:11696194-Th1 Cells, pubmed-meshheading:11696194-Th2 Cells, pubmed-meshheading:11696194-Vaccines, Conjugate
pubmed:year
2001
pubmed:articleTitle
Nasal administration of Schistosoma mansoni egg antigen-cholera B subunit conjugate suppresses hepatic granuloma formation and reduces mortality in S. mansoni-infected mice.
pubmed:affiliation
Department of Medical Microbiology and Immunology, University of Göteborg, Guldhedsgatan 10 A, SE-413 46 Göteborg, Sweden. jia-bin.sun@microbio.gu.se
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't